The latest price target for HealthEquity (NASDAQ:HQY) was reported by BMO Capital on April 9, 2026. The analyst firm set a price target for $105.00 expecting HQY to rise to within 12 months (a possible 24.04% upside). 31 analyst firms have reported ratings in the last year.

The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by BMO Capital, and HealthEquity upgraded their outperform rating.

The last upgrade for HealthEquity Inc happened on April 9, 2026 when BMO Capital raised their price target to $105. BMO Capital previously had a market perform for HealthEquity Inc.

The last downgrade for HealthEquity Inc happened on January 9, 2026 when Goldman Sachs changed their price target from N/A to $89 for HealthEquity Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on April 9, 2026 so you should expect the next rating to be made available sometime around April 9, 2027.

While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a upgraded with a price target of $85.00 to $105.00. The current price HealthEquity (HQY) is trading at is $84.65, which is out of the analyst’s predicted range.